Protagonist Therapeutics (PTGX) EBT Margin Growth (3y) (2020 - 2025)
Protagonist Therapeutics (PTGX) EBT Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 434,227.00 |
| Mar 31, 2025 | 21,910.00 |
| Dec 31, 2024 | 50,930.00 |
| Sep 30, 2024 | -39,072.00 |
| Jun 30, 2024 | 61,073.00 |
| Mar 31, 2024 | 47,038.00 |
| Dec 31, 2023 | 38,894.00 |
| Jun 30, 2022 | -458,997.00 |
| Mar 31, 2022 | 63,205.00 |
| Dec 31, 2021 | 10,089.00 |
| Sep 30, 2021 | -18,584.00 |
| Jun 30, 2021 | -128,747.00 |
| Mar 31, 2021 | -31,669.00 |
| Dec 31, 2020 | -7,783.00 |
| Sep 30, 2020 | 22,579.00 |